Royalty Pharma plc (RPRX) revenue & profit
Royalty Pharma plc (RPRX): revenue $2.4B, net income $770.9M in 2025; latest quarter +16.5% year over year. From SEC filings.
$2.4BRevenue 2025
TickerRPRX (Nasdaq)
IndustryOther
Revenue 2025$2.4B
Net income 2025$770.9M
Net margin32.4%
Annual revenue growth+5.1%
Latest quarter (2026 Q2) · Revenue$674.1M
vs. same quarter last year+16.5%
Latest quarter · Net income$17.9M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $2.2B | $42.8M | |
| 2023 | $2.4B | $1.1B | |
| 2024 | $2.3B | $859M | |
| 2025 | $2.4B | $770.9M |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.